Nyxoah SA Ordinary Shares (NYXH) is a publicly traded Healthcare sector company. As of May 21, 2026, NYXH trades at $2.88 with a market cap of $127.49M and a P/E ratio of 0.00. NYXH moved +0.00% today. Year to date, NYXH is -39.15%; over the trailing twelve months it is -62.86%. Its 52-week range spans $2.72 to $11.87. Analyst consensus is buy with an average price target of $7.96. Rallies surfaces NYXH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own NYXH include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nyxoah SA Ordinary Shares.
| Metric | Value |
|---|---|
| Price | $2.88 |
| Market Cap | $127.49M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.87 |
| 52-Week Low | $2.72 |
| Volume | 130 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover NYXH: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.96.